Related Experiment Video
Updated: Aug 4, 2026
07:02
Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)
Published on: September 14, 2010
Kaposi's sarcoma in renal allograft recipients
Cancer
|August 1, 1978
Summary
Kaposi's sarcoma is a rare but aggressive cancer in immunosuppressed patients. Early diagnosis and stopping immunosuppressive drugs can lead to favorable responses.
Area of Science:
- Oncology
- Immunology
- Transplantation
Background:
- Kaposi's sarcoma (KS) is a rare malignancy that can develop in immunosuppressed individuals.
- Immunosuppression, often necessary for organ transplant recipients, increases the risk of opportunistic infections and cancers.
- Rapid progression of KS poses a significant threat to patient health.
Observation:
- Histologic examination is crucial for the early diagnosis of Kaposi's sarcoma.
- Mucocutaneous vascular lesions in renal allograft recipients may indicate underlying KS.
- Gastrointestinal bleeding can be an presenting symptom of Kaposi's sarcoma in this population.
Findings:
- Prompt diagnosis and interruption of antirejection therapy are vital.
- Withdrawal of immunosuppressive agents led to favorable outcomes in four out of five patients diagnosed preterminally.
- Kaposi's sarcoma should be considered in renal allograft recipients presenting with mucocutaneous lesions and gastrointestinal bleeding.
Implications:
- Early detection and management strategies are critical for improving outcomes in immunosuppressed patients with Kaposi's sarcoma.
- Reducing immunosuppression can be an effective therapeutic approach.
- Awareness of KS as a differential diagnosis in transplant recipients with specific symptoms is essential for timely intervention.
Related Concept Videos
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...